Leidse hoogleraren vanaf 1575

Johannes Marinus Antonius van Gerven (Joop)

Geboren
1958-08-24 te Leiden, Nederland
Geslacht
Man

Promotie (1990)

Type examen
Promotie
Datum
1990-02-21
Plaats
Leiden
Proefschrift
Aldose reductase inhibitor treatment in diabetic complications

Gewoon Hoogleraar (2004)

Benoeming
Gewoon Hoogleraar
Faculteit
Geneeskunde
Vakgebied
Farmacologie, Neurologie, Psychiatrie
Leeropdracht
Klinische neuropsychofarmacologie
Datum benoeming
2004
Datum oratie
2005-06-21
Titel oratie
Het benevelde brein. De Delyside-challenge-test van Sandoz

Publicaties

Wetenschappelijk
  • Klaassens B.L., Rombouts S.A.R.B., Winkler A.M., Van Gorsel H.C., Van der Grond J. & Gerven J M.A. van. (2017), Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation, Human Brain Mapping 38(1): 308-325.
  • Alvarez-Jimenez R., Groeneveld G.J., Gerven J.M. van, Goulooze S.C., Baakman A.C., Hay J.L. & Stevens J. (2016), Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects., British Journal of Clinical Pharmacology 82: 1011-1021.
  • Cole D.M., Oei N.Y.L., Soeter R.P., Both S., Van Gerven J.M.A., Rombouts S.A.R.B. & Beckmann C.F. (2013), Dopamine-dependent architecture of cortico-subcortical network connectivity., Cerebral Cortex 23(7): 1509-1516.
  • Khalili-Mahani N., Chang C., Van Osch M.J., Veer I.M., Van Buchem M.A., Dahan A., Beckmann C.F., Van Gerven J.M.A. & Rombouts S.A.R.B. (2013), The impact of "physiological correction" on functional connectivity analysis of pharmacological resting state fMRI., NeuroImage 65: 499-510.
  • Klumpers L.E., Cole D.M., Khalili-Mahani N., Soeter R.P., Te Beek E.T., Rombouts S.A.R.B. & Van Gerven J.M.A. (2012), Manipulating brain connectivity with O-tetrahydrocannabinol: A pharmacological resting state FMRI study, NeuroImage 63(3): 1701-1711.
  • Khalili-Mahani N., Zoethout R.M., Beckmann C.F., Baerends E. J., De Kam M.L., Soeter R.P., Dahan A., Van Buchem M.A., Gerven J.M. & Rombouts S.A.R.B. (2012), Effects of morphine and alcohol on functional brain connectivity during "resting state": a placebo-controlled crossover study in healthy young men, Human Brain Mapping 33(5): 1003-1018.
  • Zuurman L., Roy C., Schoemaker R.C., Hazekamp A., Den Hartigh J., Bender J.C.M.E., Verpoorte R., Pinquier J., Cohen A.F. & Gerven J.M.A. van (2008), Effect of intrapulmonary tetrahydrocannabinol administration in humans, Journal of Psychopharmacology 22: 707-716.
  • Brisbane-Roch C, Dingemanse J., Koberstein R., Hoever P., Aissaoui H., Flores S., Mueller C., Gerven J.M.A. van, Haas S.L.. de, Hess P., Qiu C., Buchmann S., Scherz M., Weller T., Fischli W., Clozel M. & Jenck F. (2007), Promotion of sleep by targeting the orexin system in rats, dogs and humans, Nature Medicine 13: 150-155.
  • Haas S. de, Otte A., Weerd A. de, Erp G van, Cohen A.F. & Gerven J.M.A. van (2007), Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy, Journal of clinical sleep medicine 3: 473-478.
  • Haas S. de, Dingemanse J., Hoever P., Cohen A.F. & Gerven J.M.A. van (2007), Pseudo-hallucinations after zolpidem intake: A case report, Journal of Clinical Psychopharmacology 27: 728-730.
  • Kasteleijn-Nolst Trenité D.G.A.., French J.A., Hirsch E., Macher J.P., Meyer B.U., Grosse P.A., Abou-Khalil B.W., Rosenfeld W.E., Gerven J.M.A. van, Novak G.P., Parmeggiani L., Schmidt B., Gibson D. & Guerrini R. (2007), Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study., Epilepsy Research 74: 193-200.
  • Hazekamp A., Ruhaak R., Zuurman L., Gerven J.M.A. van & Verpoorte R. (2006), Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol, Journal of Pharmaceutical Sciences 95: 1308-1317.
  • Haas S, Visser S.J. de, Post J.P. van der, Smet M. de, Schomaker R.C., Rijnbeek B., Cohen A.F., Vega J., Agrawal N.G., Goel T.V., Simpson R.C., Pearson L.K., Hesney M., Murphy M. & Gerven J.M.A. van (2006), Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAA {alpha}2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers, Journal of Psychopharmacology.
  • Dumont G.J.H., Visser S.J. de, Cohen A.F. & Gerven J.M.A. van (2005), Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects, British Journal of Clinical Pharmacology 59: 495-510.
  • Zuurman L., Roy C., Schoemaker H.C., Hartigh J. den, Bender J.C.M.E., Pinquier J., Cohen A.F. & Gerven J.M.A. van (2005), Effect of THC administration in humas: methodology study for further pharmacodynamic studies with cannabinoid agonist or antagonist., British Journal of Clinical Pharmacology 59(5): 625.
  • Dumont G.J.H., Visser S.J. de, Cohen A.F. & Gerven J.M.A. van (2005), Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy volunteers., British Journal of Clinical Pharmacology 59: 495-510.
  • Post J.P. van der, Visser S.J. de, Kam M.L. de, Woelfler M., Hilt D.C., Vornov J., Burak E.S., Bortey E., Slusher B.S., Limsakun T., Cohen A.F. & Gerven J.M.A. van (2005), The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693., British Journal of Clinical Pharmacology 60: 128-136.
  • Post J.P. van der, Visser S.J. de, Kam M.L. de, Woelfler M., Hilt D.C., Vornov J., Burak E.S., Bortey E., Slusher B.S., Limsakun T., Cohen A. F. & Gerven J.M.A. van (2004), The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693, British Journal of Clinical Pharmacology.
  • Post J.P. van der, Visser S.J. de, Schoemaker R.C., Cohen A.F. & Gerven J.M.A. van (2004), Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of 1 3 mg sustained release tablet of rilmenidine in hypertensive patients, Journal of Psychopharmacology 18: 221-227.
  • Post J.P. van der, Waal P.P. de, Kam M.L. de, Cohen A.F. & Gerven J.M.A. van (2004), No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity, Journal of Psychopharmacology 18: 109-114.
  • Dubois E.A., Franson K.L., Gerven J.M.A. van, Bolk J.H. & Cohen A. F. (2004), Integration of training in pharmacology and pharmacotherapy in the medical curriculum in Leiden, the Netherlands, Nederlands Tijdschrift voor Geneeskunde 148(4): 194-199.
  • Pieters M.S.M., Steveninck A.F., Schoemaker R.C., Kroon J.M., Gerven J.M.A. van & Cohen A. F. (2003), The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers., Journal of Psychopharmacology 17(3): 269-272.
  • Visser S.J. de, Post J. van der, Waal P.P. de, Cornet F., Cohen A. F. & Gerven J.M.A. van (2003), Biomarkers for the effects of benzodiazepines in healthy volunteers., British Journal of Clinical Pharmacology 55: 39-50.
  • Kemme M.J.B., Post J. van der, Schoemaker R.C., Straub M., Cohen A. F. & Gerven J.M.A. van (2003), Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension., British Journal of Clinical Pharmacology 55: 518-525.
  • Post J. van der, Noordzij L.A.W., Kam M.L. de, Blauw G.J., Cohen A. F. & Gerven J.M.A. van (2002), Evaluation of tests of central nervous system performance after hypoxia for a model for cognitive impairment., Journal of Psychopharmacology 16: 337-343.
  • Post J.A.M. van der, Noordzij L.A.W., Kam M.L. de, Blauw G.J., Cohen A. F. & Gerven J.M.A. van (2002), Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment, J Psychopharmacol 16: 337-343.
  • Roode A. de, Gerven J.M.A. van, Schoemaker R.C., Engbers F.H.M., Olieman W., Kroon J.R., Cohen A. F. & Bovill J.G. (2000), A comparison of the effects of propofol and midazolam on memory during two levels of sedation by using target-controlled infusion., Anesthesia and Analgesia 91: 1056-1061.
  • Steveninck A.L. van, Berckel B.N.M. van, Schoemaker R.C., Breimer D.D., Gerven J.M.A. van & Cohen A.F. (1999), The sensitity of pharmacodynamic tests for central nervous system effects of drugs on the effects of sleep deprivation, Psychopharmacology 3: 10-17.
  • Haarst A.D. van, Gerven J.M.A. van, Cohen A.F., Smet M. de, Sterrett A., Brik K.L., Fisher A.L., Puy M.E. de, Goldberg M.R. & Musson D.G. (1999), The effects of moclobemide on the pharmacokinetics of the 5-HT1b/1d agonist rizatriptan in healthy volunteers., British Journal of Clinical Pharmacology 48: 190-196.
  • Faaij R.A., Gerven J.M.A. van, Jolivet-Landreau I., Masclee A.A.M., Vendrig E.M., Schoemaker R.C., Jacobs L.D. & Cohen A.F. (1999), Onset of action during on-demand treatment with Maalox suspension or low-dose ranitidine for heartburn, Alimentary Pharmacology and Therapeutics 13(12): 1605-1610.
  • Steveninck A.L. van, Berckel B.N.M. van, Schoemaker R.C., Breimer D.D., Gerven J.M.A. van & Cohen A.F. (1999), The sensitivity of pharmacodynamic tests for central nervous system effects of drugs on the effects of sleep deprivation., Journal of Psychopharmacology 3: 10-17.
  • Lammers G.J., Dijk J.G. van, Ferrari M.D., Gerven J.M.A. van, Declerck A.C. & Troost J. (1999), Gammahydroxyboterzuur dient beschikbaar te blijven voor patiënten met narcolepsie., Nederlands Tijdschrift voor Geneeskunde 143: 2062-2063.
  • Haarst A.D. van, Klooster G.A.E., Gerven J.M.A. van, Schoemaker H.C., Oene J.C. van, Burggraaf J., Coene M.-C. & Cohen A.F. (1998), The influence of cisapride and clarithromycin on QT intervals in healthy volunteers, Clinical Pharmacology & Therapeutics 64: 542-546.
  • Gerven J.M.A. van, Uchida E., Uchida N., Pieters M.S.M., Meinders A.J., Schoemaker R.C., Nanhekhan L.V., Visser S.J. de, Altorf B., Yasuda K., Yasuhara H. & Cohen A.F. (1998), Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy male and female volunteers. An interethnic comparative study between Japanese and Caucasian volunteers., The Journal of Clinical Pharmacology 38: 1129-1136.
  • Gerven J.M.A. van, Uchida E., Uchida N., Pieters M.S.M., Meinders A.J., Schoemaker H.C., Nanhekhan L.V., Visser S.J. de, Altorf B., Yasuda K., Yasuhara H. & Cohen A.F. (1998), Pharmacodynamic and pharmacokinetics of a single oral dose of nitrazeam in healthy volunteers: an interethnic comparative study between Japanese and European volunteers, The Journal of Clinical Pharmacology 38: 1129-1136.
  • Gerven J.M.A. van, Gijsman H.J., Verkes R.J. & Cohen A.F. (1998), Cognitieve en psychotische effecten na stopzetting van chronisch cannabisgebruik, Nederlands Tijdschrift voor Geneeskunde 142: 1046-1047.
  • Gerven J.M.A. van, Ychida E. & Pieters M.S.M. (1998), Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy male and female volunteers: an interethnic comparative study of Japanese and Caucasian volunteers, British Journal of Clinical Pharmacology 45: 183-215.
  • Gijsman H.J., Gerven J.M.A. van, Tieleman M.C., Schoemaker R.C., Pieters M.S.M., Ferrari M.D., Cohen A.F. & Kempen G.M.J. van (1998), Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers, International Clinical Psychopharmacology 18: 289-295.
  • Schoemaker R.C., Gerven J.M.A. van & Cohen A.F. (1998), Estimating potency for the Emax-model without attaining maximal effects., Journal of Pharmacokinetics and Biopharmaceutics 26: 581-593.
  • Gijsman H.J., Gerven J.M.A. van, Tieleman M.C., Schoemaker H.C., Pieters M.S.M., Ferrari M.D., Cohen A.F. & Kempen G.M.J. van (1998), Pharmacokinetic and pharmacodynamic profile of oral and intravenous metachlorophenylpiperazine in healthy volunteers, Journal of Clinical Psychopharmacology 18(4): 289-295.
  • Steyerberg E.W., Keizer H.J., Messemer J.E., Toner G.C., Schraffordt Koops H., Fossa S.D., Gerven J.M.A. van, Sleyfer D.T., Donohue J.P. & Habbema J.D.F. (1997), Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor., Cancer 79: 345-355.
Vakpublicaties
  • Haas S. de, Weerd A.W. de, Otte A., Kasteleijn-Nolst Trinite DG, Gerven J.M.A. van, Erp G., Kam M. de & Cohen A. F. (2003), Epidemiologie van slaapproblemen bij patienten met partiele epilepsie., Tijdschrift voor Neurologie & Neurochirurgie 104: 16-17.
  • Verkes R.J., Gijsman H.J., Pieters M.S.M., Pennings E.J.M., Schoemaker R.C., Gerven J.M.A. van & Cohen A.F. (1998), Cognitive and serotonergic function in exstasy-users and controls. onbekend: LUMC.
  • Gerven J.M.A. van, Gijsman H.J., Verkes R.J. & Cohen A.F. (1998), Cognitieve en psychotische effecten na stopzetting van chronisch cannabisgebruik, Nederlands Tijdschrift voor Geneeskunde 142: 1046-1047.
Overig
  • Zuurman L., Roy C., Asset G., Amatsaleh A., Guimaraes L., Pinquier J., Cohen A.F. & Gerven J.M.A. van (2007), The effects of the novel CB1 antagonist AVE1625 on the THC-induced changes on central nervous system effects and heart rate, Clinical Pharmacology & Therapeutics 81(suppl 1:S4).
  • Gerven J.M.A. van (2007), Behandeling van neuropathische pijn: Boerhaave Instituut. [overig]
  • Haas S. de, Visser S.J. de, Post J.P. van der, Smet M. de, Schomaker R.C., Rijnbeek B., Cohen A.F., Vega J., Agrawal N.G., Goel T.V., Simpson R.C., Pearson L.K., Li S., Hesney M., Murphy M. & Gerven J.M.A. van (2006), The selective effects of two different GABA A Alpha2,3 subtype-selecctive agonist compared to lorazepam., Journal of Psychopharmacology A15.
  • Haas S. de, Visser S.J. de, Post J.P. van der, Smet M. de, Schomaker R.C., Rijnbeek B., Cohen A.F., Vega J., Agrawal N.G., Goel T.V., Simpson R.C., Pearson L.K., Li S., Hesney M., Murphy M. & Gerven J.M.A. van (2006), Pharmacodynamic effects of TPA023, a GABA-A subtype selective agonist, compared with lorazepam and placebo in healthy volunteers., Br.J.Clin.Pharmacol. 61(5): 627.

Links

Link naar deze pagina
http://hoogleraren.leidenuniv.nl/id/3514

©2015 Universitaire Bibliotheken Leiden www.bibliotheek.leidenuniv.nl